SGMT
Sagimet Biosciences Inc. Series A
11.20$
+6.8%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | |
| 0.00 | 0.01 | 0.01 | 0.01 | – | – | – | |
| 0.00 | -0.01 | -0.01 | -0.01 | 0.11 | – | – | |
| 0.38 | 0.37 | 0.87 | 1.12 | 1.09 | 1.23 | 1.21 | |
| 0.26 | 0.15 | 0.20 | 0.28 | 0.71 | 0.51 | 0.55 | |
| 0.63 | 0.51 | 1.07 | 1.40 | 1.80 | 1.74 | 1.76 | |
| -0.64 | -0.51 | -1.07 | -1.40 | -1.69 | -1.74 | -1.76 | |
| 0.00 | 0.00 | – | – | – | – | – | |
| -0.64 | -0.51 | -1.10 | -1.38 | -1.53 | -1.45 | -1.58 | |
| 0.00 | -0.01 | -1.07 | -1.43 | -0.16 | – | – | |
| -0.64 | -0.51 | -1.10 | -1.38 | -1.53 | -1.45 | -1.58 | |
| -0.64 | -0.51 | -1.07 | -1.40 | -1.53 | -1.45 | -1.58 |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.